Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





METHYL 2-CYANOACRYLATE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 137-05-3; **Chemical Formula:** CH2=C(C=N)COOCH3
No previous limit existed for methyl 2-cyanoacrylate. OSHA proposed establishing a limit of 2 ppm as an 8-hour TWA and 4 ppm as a STEL, based on the ACGIH recommendation, and the final rule establishes these limits. NIOSH (Ex. 8-47, Table N1) concurred with the selection of these limits. Methyl 2-cyanoacrylate is a colorless, viscous liquid.
In a personal communication to the ACGIH TLV Committee in 1985, Eastman Kodak reported on the toxicity of methyl 2-cyanoacrylate in experimental animals. The oral LD(50) in rats is reported to be 1.6 to 3.2 g/kg, and the dermal LD(50) in guinea pigs is 10 ml/kg. The adverse effects reported in laboratory animals are slight irritation of the skin and corneal damage. An inhalation LC(50) of 101 ppm has been reported in rats exposed for six hours to methyl 2-cyanoacrylate. Repeated exposures (six hours/day for five days/week) to 31.3 ppm for a total of 12 exposures caused only a slight decrease in the rate of weight gain in rats and no nasal or tracheal lesions or systemic toxicity. No changes were observed in rats similarly exposed to 3.1 ppm (Eastman Kodak 1985, as cited in ACGIH 1986/Ex. 1-3, p. 383).
In a simulated workbench exposure, McGee and co-workers reported nasal irritation in humans at 3 ppm and eye irritation at 5 ppm (McGee, Oglesby, Raleigh, and Fassett 1968/Ex. 1-424). There are no reports of occupational poisonings. No comments, other than NIOSH’s, were received on OSHA’s proposed PELs for this substance.
The report by McGee et al. (1968/Ex. 1-424) clearly establishes that employees are at risk of nasal irritation on exposure to 3 ppm or above and of eye irritation at 5 ppm or above. The Agency has determined that these adverse effects constitute material impairment of health and should be avoided in the workplace. Therefore, to substantially reduce these significant risks, OSHA is establishing a 2-ppm 8-hour TWA limit and a 4-ppm STEL for methyl 2-cyanoacrylate in the final rule.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue